Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1099)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
215
Price
$494.74
Total Value
$106.37K
Shares Held After
650
% of Holdings
24.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
185
Price
$493.40
Total Value
$91.28K
Shares Held After
865
% of Holdings
17.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
243
Price
$492.44
Total Value
$119.66K
Shares Held After
1,050
% of Holdings
18.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
485
Price
$491.33
Total Value
$238.30K
Shares Held After
1,293
% of Holdings
27.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,808
Price
$490.52
Total Value
$886.86K
Shares Held After
1,778
% of Holdings
50.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,290
Price
$489.68
Total Value
$1.12M
Shares Held After
3,586
% of Holdings
39.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,429
Price
$488.63
Total Value
$1.19M
Shares Held After
5,876
% of Holdings
29.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
926
Price
$487.55
Total Value
$451.47K
Shares Held After
8,305
% of Holdings
10.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$486.42
Total Value
$194.08K
Shares Held After
9,231
% of Holdings
4.1%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,438
Price
$17.87
Total Value
$43.57K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
35,710
Price
$19.32
Total Value
$689.83K
Shares Held After
964,161
% of Holdings
3.6%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
14,290
Price
$18.78
Total Value
$268.32K
Shares Held After
999,871
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
57
Price
$325.67
Total Value
$18.56K
Shares Held After
21,227
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
75
Price
$324.88
Total Value
$24.37K
Shares Held After
21,284
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
210
Price
$323.84
Total Value
$68.01K
Shares Held After
21,359
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
96
Price
$323.01
Total Value
$31.01K
Shares Held After
21,569
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
79
Price
$321.82
Total Value
$25.42K
Shares Held After
21,665
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
59
Price
$320.81
Total Value
$18.93K
Shares Held After
21,744
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
28
Price
$320.01
Total Value
$8.96K
Shares Held After
21,803
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
29
Price
$319.03
Total Value
$9.25K
Shares Held After
21,831
% of Holdings
0.1%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
12,000
Price
$9.06
Total Value
$108.72K
Shares Held After
226,581
% of Holdings
5.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
German Christopher Paul — Corporate Controller & CAO
Shares
5,614
Price
$89.56
Total Value
$502.79K
Shares Held After
160
% of Holdings
97.2%
PepGen Inc. (PEPG)
McArthur James G — Director
Shares
131
Price
$6.33
Total Value
$828.58
Shares Held After
296,326
% of Holdings
0.0%
PepGen Inc. (PEPG)
McArthur James G — Director
Shares
5,144
Price
$6.23
Total Value
$32.05K
Shares Held After
296,457
% of Holdings
1.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,437
Price
$475.30
Total Value
$1.16M
Shares Held After
15,122
% of Holdings
13.9%
PepGen Inc. (PEPG)
Donnelly Noel — Chief Financial Officer
Shares
52
Price
$6.33
Total Value
$328.90
Shares Held After
111,603
% of Holdings
0.0%
PepGen Inc. (PEPG)
Donnelly Noel — Chief Financial Officer
Shares
2,032
Price
$6.23
Total Value
$12.66K
Shares Held After
111,655
% of Holdings
1.8%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
26,279
Price
$36.28
Total Value
$953.37K
Shares Held After
357,554
% of Holdings
6.8%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
19,244
Price
$35.56
Total Value
$684.23K
Shares Held After
383,833
% of Holdings
4.8%
VERACYTE, INC. (VCYT)
Leite John — Chief Commercial Officer-CLIA
Shares
5,260
Price
$35.19
Total Value
$185.08K
Shares Held After
107,580
% of Holdings
4.7%
VERACYTE, INC. (VCYT)
McGuire Annie — SVP, General Counsel
Shares
1,664
Price
$36.34
Total Value
$60.47K
Shares Held After
94,706
% of Holdings
1.7%
VERACYTE, INC. (VCYT)
McGuire Annie — SVP, General Counsel
Shares
4,994
Price
$35.29
Total Value
$176.26K
Shares Held After
96,370
% of Holdings
4.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
223
Price
$325.67
Total Value
$72.62K
Shares Held After
61,805
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
291
Price
$324.88
Total Value
$94.54K
Shares Held After
62,028
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
818
Price
$323.84
Total Value
$264.90K
Shares Held After
62,319
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
374
Price
$323.01
Total Value
$120.81K
Shares Held After
63,137
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
309
Price
$321.82
Total Value
$99.44K
Shares Held After
63,511
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
230
Price
$320.81
Total Value
$73.79K
Shares Held After
63,820
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
109
Price
$320.01
Total Value
$34.88K
Shares Held After
64,050
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
114
Price
$319.03
Total Value
$36.37K
Shares Held After
64,159
% of Holdings
0.2%
PepGen Inc. (PEPG)
STRECK PAUL — EVP, Head of R&D
Shares
47
Price
$6.29
Total Value
$295.54
Shares Held After
76,226
% of Holdings
0.1%
PepGen Inc. (PEPG)
STRECK PAUL — EVP, Head of R&D
Shares
1,832
Price
$6.23
Total Value
$11.41K
Shares Held After
76,273
% of Holdings
2.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
21,097
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
21,305
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
21,577
% of Holdings
3.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
22,344
% of Holdings
1.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
22,694
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
22,983
% of Holdings
0.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
23,198
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
23,300
% of Holdings
0.5%
Showing 601–650 of 1099 transactions (page 13 of 22)